The Journal of Phytopharmacology, 2021;10(5):319-322 ; DOI:10.31254/phyto.2021.10507
Repurposed Drugs and Covid-19 Pandemic-What and Why?
1. Department of Pharmacology and Toxicology, CVSc and AH, OUAT, Bhubaneswar, India
*Author to whom correspondence should be addressed.
Received: 22nd July, 2021 / Accepted: 9th August, 2021
New remedies for COVID-19 are the demand of time as we live in a phase beyond containment in this current pandemic. Its impractical to think of a quick relief immediately as drug development from a scratch is not an easy and quick process. Repurposing of drugs might be a method where drugs already tested safe to humans will be redeployed to curb a disease. Use of repurposed drugs alone may not be able to produce a clear and advantageous clinical result where a carefully combined cocktails could be a good alternative, as seen in treatment of HIV in the 1990s. But the most important question now is now, which combination? This article gives a detailed review on repurposed drugs under clinical trial for COVID-19 to find out a suitable cocktail.
Antiviral, COVID-19, Drug repurposing, SARS.
HOW TO CITE THIS ARTICLE
Dash JR. Repurposed Drugs and Covid-19 Pandemic-What and Why? J Phytopharmacol 2021; 10(5):319-322. doi: 10.31254/phyto.2021.10507
Creative Commons (CC) License-
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY 4.0) license. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. (http://creativecommons.org/licenses/by/4.0/).
Copyright
Copyright © 2021 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0.